Publicacións en colaboración con investigadores/as de Medical University of South Carolina (16)

2022

  1. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  2. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2017

  1. New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality

    Pediatric Critical Care Medicine, Vol. 18, Núm. 1, pp. 8-16

2016

  1. Comparison of Pediatric Severe Sepsis Managed in U.S. and European ICUs

    Pediatric Critical Care Medicine, Vol. 17, Núm. 6, pp. 522-530

  2. Concordant and Discordant Exudates and Their Effect on the Accuracy of Light's Criteria to Diagnose Exudative Pleural Effusions

    American Journal of the Medical Sciences, Vol. 352, Núm. 6, pp. 549-556

2015

  1. Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study

    Critical Care, Vol. 19, Núm. 1

2014

  1. Characteristics of patients with yellow nail syndrome and pleural effusion

    Respirology, Vol. 19, Núm. 7, pp. 985-992

2013

  1. Can tuberculous pleural effusions be diagnosed by pleural fluid analysis alone?

    International Journal of Tuberculosis and Lung Disease, Vol. 17, Núm. 6, pp. 787-793

  2. The art of pleural fluid analysis

    Clinical Pulmonary Medicine, Vol. 20, Núm. 2, pp. 77-96

2011

  1. Diagnostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Pleural Effusions of Cardiac Origin

    Archivos de Bronconeumologia, Vol. 47, Núm. 5, pp. 246-251

2010

  1. Diagnosing tuberculous pleural effusion using clinical data and pleural fluid analysis. A study of patients less than 40 years-old in an area with a high incidence of tuberculosis

    Respiratory Medicine, Vol. 104, Núm. 8, pp. 1211-1217

1999

  1. Quantification of N-(glucitol)ethanolamine and N-(carboxymethyl)serine: Two products of nonenzymatic modification of aminophospholipids formed in vivo

    Analytical Biochemistry, Vol. 272, Núm. 1, pp. 48-55

1997

  1. Carboxymethylethanolamine, a biomarker of phospholipid modification during the Maillard reaction in vivo

    Journal of Biological Chemistry, Vol. 272, Núm. 28, pp. 17473-17479

  2. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein

    Biochemical Journal, Vol. 322, Núm. 1, pp. 317-325

1996

  1. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions

    Nephrology Dialysis Transplantation

  2. The advanced glycation end product, N∈-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions

    Journal of Biological Chemistry, Vol. 271, Núm. 17, pp. 9982-9986